Connection
Andrew Haynes to Anti-Bacterial Agents
This is a "connection" page, showing publications Andrew Haynes has written about Anti-Bacterial Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.320 |
|
|
|
-
Haynes AS, Maples H, Parker S. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):308-318.
Score: 0.114
-
Haynes AS, Prinzi A, Silveira LJ, Parker SK, Lampe JN, Kavanaugh JS, Horswill AR, Fish D. Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections. Microbiol Spectr. 2022 08 31; 10(4):e0103922.
Score: 0.107
-
Haynes AS, MacBrayne CE, Parker SK. Impact of Antimicrobial Stewardship Bundle on Inpatient Use of Highly Bioavailable Antibacterials. Hosp Pediatr. 2021 05; 11(5):509-514.
Score: 0.099